Copyright
©The Author(s) 2016.
World J Stem Cells. Apr 26, 2016; 8(4): 118-135
Published online Apr 26, 2016. doi: 10.4252/wjsc.v8.i4.118
Published online Apr 26, 2016. doi: 10.4252/wjsc.v8.i4.118
Figure 1 Representation of the workflow for the derivation of patient-specific induced stem cells from foetal or somatic cells and successively their use for the development of personalized therapy protocols.
CVS: Chorionic villus sampling; AF: Amniotic fluid; hiPSCs: Human induced pluripotent stem cells.
- Citation: Spitalieri P, Talarico VR, Murdocca M, Novelli G, Sangiuolo F. Human induced pluripotent stem cells for monogenic disease modelling and therapy. World J Stem Cells 2016; 8(4): 118-135
- URL: https://www.wjgnet.com/1948-0210/full/v8/i4/118.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v8.i4.118